This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top-Ranked ETFs, Stocks From Top Sector of the Last Decade
by Sweta Killa
Amid a plethora of challenges, Wall Street was on a spectacular run over the last decade, rising from the depths of the financial crisis and Great Recession.
Here's Why You Should Hold on to Intuitive Surgical for Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.
Here's Why You Should Invest in Patterson Companies Stock Now
by Zacks Equity Research
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
by Zacks Equity Research
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.
6 MedTech Stocks That are Set to Beat the Market in 2020
by Trina Mukherjee
Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (DXCM) Outperforming Other Medical Stocks This Year?
Here's Why You Should Add DexCom (DXCM) to Your Portfolio
by Zacks Equity Research
DexCom (DXCM) raises its 2019 revenue and EPS guidance.
DexCom (DXCM) Up 16.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (DXCM) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: DexComm, Forterra, Vista Outdoor, Hibbett Sports and Target
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DexComm, Forterra, Vista Outdoor, Hibbett Sports and Target
DexCom, Inc. (DXCM) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor DexCom, Inc. (DXCM).
5 Best Bets in View Before the Curtain Falls on November
by Zacks Equity Research
Solid economic data, favorable earnings reports and subsiding trade war anxiety bump up stocks in November. Here are top five momentum stocks that are poised to grow.
6 Top Momentum Stocks in November With More Room to Run
by Nalak Das
A temporary trade truce between the United States and China will bolster business confidence and stabilize overall U.S. economic growth.
Top Ranked Momentum Stocks to Buy for November 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 29th
5 Screaming Hot Strong Buy Stocks
by David Bartosiak
Do not let this pullback opportunity pass you by as the market has plenty of room to run.
Digital Diabetes Management Gains Momentum: 3 Stocks in Focus
by Trina Mukherjee
With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.
The Zacks Analyst Blog Highlights: DexCom, Forterra, NeoPhotonics, Ironwood and Cardtronics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DexCom, Forterra, NeoPhotonics, Ironwood and Cardtronics
5 Best-Performing, Top-Ranked Growth Stocks of November
by Nalak Das
Wall Street's impressive bull run is likely to continue in the near term. At this stage, it will be prudent to invest in growth stocks with a favorable Zacks Rank.
5 Growth Stocks to Buy as U.S.-China Trade Tiff Eases
by Zacks Equity Research
The United States and China finally seem to be making progress on a phase one deal. Here are our five top growth stocks that are poised for fair returns.
MEDNAX (MD) Ties Up With Homestead to Expand in Florida
by Zacks Equity Research
MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.
Dexcom (DXCM) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Dexcom (DXCM) gains from several positive developments.
Digital Health Gaining Momentum: 3 MedTech Stocks in Focus
by Trina Mukherjee
Digital health is committed to changing the face of healthcare as evident from its innovative solutions for the betterment of patients' lives.
Earnings Estimates Moving Higher for DexCom (DXCM): Time to Buy?
by Zacks Equity Research
DexCom (DXCM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The Zacks Analyst Blog Highlights: comScore, Communications Systems, Vista Outdoor, Forterra and DexCom
by Zacks Equity Research
The Zacks Analyst Blog Highlights: comScore, Communications Systems, Vista Outdoor, Forterra and DexCom
5 Winning Stocks Halfway Through Q4
by Zacks Equity Research
We have highlighted stocks that have done well so far in the fourth quarter and have room to scale higher in the near future.